Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
News
Menu
Research & Development

Munich partnership controls light pulses in MIR range

06 Jun 2022

Development offers potential to boost reliability of medical diagnostics using infrared lasers.

An international team of laser physicists of the attoworld team at LMU, and the Max Planck Institute of Quantum Optics (both in Munich, Germany) has achieved what they describe as “unprecedented control over light pulses in the mid-infrared wavelength range”.

Ultrashort infrared light pulses are the key to a wide range of technological applications. The oscillating infrared light field can excite molecules in a sample to vibrate at specific frequencies, or drive ultrafast electric currents in semiconductors.

Anyone intending to exploit the oscillating waveform of ultrashort light pulses, to drive cutting-edge electro-optical processes for example, faces the same question — how to best control the waveform themselves. The generation of ultrashort pulses with adjustable waveforms has been demonstrated in different wavelength ranges like the UV-visible and the near-infrared.

The work is reported in Nature Photonics (open access paper).

Physicists from the attoworld team at the LMU, the Max Planck Institute of Quantum Optics (MPQ) and the Hungarian Center for Molecular Fingerprinting (CMF) have now succeeded in generating ultrashort mid-infrared pulses and precisely controlling their electric-field waveforms. With this infrared waveform manipulator at hand, new possibilities of optical control for biomedical applications and quantum electronics come into reach, says the group.

Stabilized Laser

The basis for the new mid-infrared source is a stabilized laser system that generates light pulses with a precisely defined waveform at near-infrared wavelengths. The pulses consist of only one oscillation of the light wave and are thus only a few femtoseconds long. When these pulses are sent into a suitable nonlinear crystal, the generation of long-wavelength infrared pulses can be induced by taking advantage of complex frequency-mixing processes.

In this way, the team succeeded in producing light pulses with an exceptionally large spectral coverage of more than three optical octaves, from 1µm to 12µm. The researchers were not only able to understand and simulate the underlying physics of the mixing processes, but also developed a new approach to precisely control the oscillations of the generated mid-infrared light via the tuning of the laser input parameters.

Speeding up electronics

The resulting adjustable waveforms can, for example, selectively trigger certain electronic processes in solids, which could allow to achieve much higher electronic signal processing speeds in future. "On this basis, one could envision the development of light-controlled electronics," said Philipp Steinleitner, one of the three lead authors of the study. “If opto-electronic devices were to operate at frequencies of the generated light, you could speed up today’s electronics by at least a factor of 1000.”

The attoworld physicists are paying particular attention to the use of the new light technology for the spectroscopy of molecules. When mid-infrared light passes through a sample liquid, for example human blood, molecules in the sample begin to oscillate and in turn emit characteristic light waves.

Detecting the molecular response provides a unique fingerprint that depends on the exact composition of the sample. “With our laser technology, we have significantly expanded the controllable wavelength range in the infrared,” said Nathalie Nagl, also first author of the study. "The additional wavelengths give us the opportunity to analyze even more precisely how a mixture of molecules is composed.”

Medical diagnostics

In the attoworld group, researchers from the Broadband Infrared Diagnostics (BIRD) team led by Mihaela Zigman and the CMF Research team led by Alexander Weigel are particularly interested in measuring the precise infrared molecular fingerprints of human blood samples. The vision is to identify characteristic signatures that allow to diagnose diseases like cancer.

“In the future, our laser technology will allow our colleagues to detect previously undetectable changes in specific biomolecules such as proteins or lipids. It thus increases the reliability of future medical diagnostics using infrared laser technology,” said Maciej Kowalczyk, also first author of the study.

Schaefter und Kirchhoff GmbHAVANTES BVOmicron-Laserage Laserprodukte GmbHDelta Optical Thin Film A/STRIOPTICS GmbHOcean Insight IncAUREA TECHNOLOGY
Copyright © 2022 SPIE EuropeDesigned by Kestrel Web Services